Clinical trial
A Comparison of Two Standard Therapies in the Management of Dementia With…
NCT00208819 · Emory University, Other · Completed
Key facts
| NCT number | NCT00208819 |
|---|---|
| Title | A Comparison of Two Standard Therapies in the Management of Dementia With Agitation |
| Official title | Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies |
| Lead sponsor | Emory University, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Senile Dementia, Alzheimer Type, Dementia, Alzheimer Disease |
| Intervention type | Drug |
| Interventions | risperidone, quetiapine, olanzapine, divalproex |
| Enrollment | 50 |
| Start date | Sep 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: